Shin Nippon Biomedical Laboratories, Ltd.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: JP3379950003
JPY
1,952.00
19 (0.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROCE of 11.92%

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 17.36% and Operating profit at 15.06%

 
3

Negative results in Jun 25

4

With ROCE of 4.18%, it has a very attractive valuation with a 1.26 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

JPY 70,567 Million (Small Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.69

stock-summary
Return on Equity

14.66%

stock-summary
Price to Book

1.99

Revenue and Profits:
Net Sales:
6,478 Million
(Quarterly Results - Jun 2025)
Net Profit:
256 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.22%
0%
14.22%
6 Months
49.81%
0%
49.81%
1 Year
23.62%
0%
23.62%
2 Years
20.87%
0%
20.87%
3 Years
-13.97%
0%
-13.97%
4 Years
27.17%
0%
27.17%
5 Years
193.09%
0%
193.09%

Shin Nippon Biomedical Laboratories, Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.36%
EBIT Growth (5y)
15.06%
EBIT to Interest (avg)
26.69
Debt to EBITDA (avg)
1.88
Net Debt to Equity (avg)
0.85
Sales to Capital Employed (avg)
0.46
Tax Ratio
19.10%
Dividend Payout Ratio
42.27%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.04%
ROE (avg)
24.18%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
1.40
EV to EBIT
30.12
EV to EBITDA
15.02
EV to Capital Employed
1.26
EV to Sales
2.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.18%
ROE (Latest)
12.32%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 16.73% vs -4.40% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 124.21% vs -91.72% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,477.70",
          "val2": "5,549.50",
          "chgp": "16.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "403.50",
          "val2": "365.90",
          "chgp": "10.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.80",
          "val2": "40.60",
          "chgp": "42.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.20",
          "val2": "-1.10",
          "chgp": "-463.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "256.50",
          "val2": "114.40",
          "chgp": "124.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-52.60%",
          "val2": "-26.20%",
          "chgp": "-2.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 22.55% vs 5.42% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -11.84% vs -8.81% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32,413.80",
          "val2": "26,450.50",
          "chgp": "22.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,596.30",
          "val2": "6,030.30",
          "chgp": "-7.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "202.70",
          "val2": "138.80",
          "chgp": "46.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-230.90",
          "val2": "8.30",
          "chgp": "-2,881.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,864.60",
          "val2": "5,517.70",
          "chgp": "-11.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.10%",
          "val2": "157.40%",
          "chgp": "-6.53%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
6,477.70
5,549.50
16.73%
Operating Profit (PBDIT) excl Other Income
403.50
365.90
10.28%
Interest
57.80
40.60
42.36%
Exceptional Items
-6.20
-1.10
-463.64%
Consolidate Net Profit
256.50
114.40
124.21%
Operating Profit Margin (Excl OI)
-52.60%
-26.20%
-2.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 16.73% vs -4.40% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 124.21% vs -91.72% in Jun 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
32,413.80
26,450.50
22.55%
Operating Profit (PBDIT) excl Other Income
5,596.30
6,030.30
-7.20%
Interest
202.70
138.80
46.04%
Exceptional Items
-230.90
8.30
-2,881.93%
Consolidate Net Profit
4,864.60
5,517.70
-11.84%
Operating Profit Margin (Excl OI)
92.10%
157.40%
-6.53%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 22.55% vs 5.42% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -11.84% vs -8.81% in Mar 2024

stock-summaryCompany CV
About Shin Nippon Biomedical Laboratories, Ltd. stock-summary
stock-summary
Shin Nippon Biomedical Laboratories, Ltd.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available